Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial
PaperCitations, authors & open-access status
Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 50 citations, 2021 year and hybrid oa status.
50
Citations
2021
Year
hybrid
OA Status